openPR Logo
Press release

Drug Eluting Balloon Catheters Market Size 2024 to 2031.

04-15-2024 12:51 AM CET | Media & Telecommunications

Press release from: Report Prime

Drug Eluting Balloon Catheters Market Size 2024 to 2031.

Market Overview and Report Coverage

Drug Eluting Balloon Catheters are medical devices used in angioplasty procedures to deliver medication directly to the walls of the blocked arteries. The medication helps prevent re-blockage of the artery post procedure, reducing the need for repeat procedures. This particular market is growing at a substantial rate with a CAGR of 7.00% during the forecasted period, showing a promising future outlook.
The increasing prevalence of cardiovascular diseases, technological advancements in catheter designs, and the rising demand for minimally invasive procedures are some of the key factors driving the growth of the Drug Eluting Balloon Catheters Market. Furthermore, the growing geriatric population, who are more prone to heart diseases, is expected to further boost the demand for these devices in the coming years.
However, challenges such as stringent regulatory requirements and high costs associated with these procedures may hinder market growth to some extent. Nonetheless, advancements in drug delivery systems and ongoing research and development activities are expected to create lucrative opportunities for market players in the foreseeable future. Overall, the Drug Eluting Balloon Catheters Market is poised for significant growth and advancement in the coming years.

Get a Sample PDF of the Report:

Market Segmentation
The Drug Eluting Balloon Catheters Market Analysis by types is segmented into:
• Polyurethane
• Nylon
• Others

The drug eluting balloon catheters market types include polyurethane, nylon, and others. Polyurethane catheters are flexible and have low friction properties, while nylon catheters are strong and withstand high pressure. Other types may include silicone or PVC catheters. These different materials cater to various medical applications and patient needs, providing a wide range of options for healthcare providers. Each material has its own unique characteristics that make it suitable for different procedures and conditions.

Get a Sample PDF of the Report:

The Drug Eluting Balloon Catheters Market Industry Research by Application is segmented into:
• Hospitals
• Clinics
• Ambulatory Surgical Centers

Drug Eluting Balloon Catheters are commonly used in hospitals, clinics, and ambulatory surgical centers for the treatment of coronary artery disease. Hospitals are the primary setting for complex cardiac procedures, while clinics provide outpatient care for less severe cases. Ambulatory surgical centers offer a more convenient and cost-effective option for certain procedures. These settings all play a crucial role in providing patients with access to innovative and effective treatments using Drug Eluting Balloon Catheters.

Purchase this Report: 

In terms of Region, the Drug Eluting Balloon Catheters Market Players available by Region are:

North America:
• United States
• Canada

• Germany
• France
• U.K.
• Italy
• Russia

• China
• Japan
• South Korea
• India
• Australia
• China Taiwan
• Indonesia
• Thailand
• Malaysia

Latin America:
• Mexico
• Brazil
• Argentina Korea
• Colombia

Middle East & Africa:
• Turkey
• Saudi
• Arabia
• Korea

What are the Emerging Trends in the Global Drug Eluting Balloon Catheters market?
Some emerging trends in the global drug eluting balloon catheters market include the introduction of advanced technologies for delivering drugs more effectively, the rising prevalence of cardiovascular diseases driving demand for minimally invasive treatments, increasing focus on research and development for improving medical devices, and the adoption of drug eluting balloon catheters in developing countries to address the growing burden of heart diseases. Additionally, collaborations between healthcare providers and manufacturers for product development and training programs for healthcare professionals on the use of these devices are expected to drive further growth in the market.

Inquire or Share Your Questions If Any Before Purchasing This Report-

Major Market Players
Medtronic is a global healthcare solutions company that operates in more than 150 countries. The company offers a wide range of medical devices and technologies, including drug-eluting balloon catheters. Medtronic has a strong presence in the market and has been expanding its product portfolio through strategic acquisitions and collaborations. The company has experienced significant market growth over the years due to its innovative products and strong brand reputation.
Boston Scientific is another key player in the drug-eluting balloon catheters market. The company is known for its expertise in medical devices used in interventional cardiology and has been expanding its product offerings in this space. Boston Scientific has a strong research and development focus, leading to the development of advanced technologies in drug-eluting balloon catheters.
Abbott Laboratories is a global healthcare company that offers a diverse portfolio of products, including drug-eluting balloon catheters. The company has shown steady market growth due to its strong distribution network and focus on innovation. Abbott Laboratories has demonstrated a commitment to improving patient outcomes through its medical devices and technologies.
The sales revenue of Medtronic in 2020 was approximately $28.91 billion, while Boston Scientific reported sales revenue of around $10.7 billion in the same year. Abbott Laboratories generated sales revenue of approximately $34.61 billion in 2020. These figures indicate the significant market presence and financial performance of these companies in the drug-eluting balloon catheters market.

Purchase this Report:
Get a Sample PDF of the Report:

Check more reports on

Contact Us:
Name: Mahesh Patel
Phone: +1 507 500 7209

At, our vision is to revolutionize the market research industry by delivering unprecedented value to our clients through our audacious goal of providing unparalleled research quality, ethical practices, and affordability. We strive to empower businesses of all sizes with actionable, accurate, and unbiased insights that inform strategic decision-making, drive growth and innovation. We are committed to fostering a culture of excellence, integrity, and transparency, and to fostering lasting partnerships with our clients through affordability and dedicated client servicing.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Eluting Balloon Catheters Market Size 2024 to 2031. here

News-ID: 3463186 • Views:

More Releases from Report Prime

Hospital Air Mattresses Market Size 2024 to 2031.
Hospital Air Mattresses Market Size 2024 to 2031.
Market Overview and Report Coverage A hospital air mattress is a medical device designed to provide pressure relief and prevent pressure ulcers for patients who are bedridden or have limited mobility. These mattresses are widely used in hospitals, nursing homes, and home care settings to improve patient comfort and reduce the risk of skin breakdown. The Hospital Air Mattresses Market is expected to witness substantial growth in the coming years.
Electric Transfer Chairs Market Size 2024 to 2031.
Electric Transfer Chairs Market Size 2024 to 2031.
Market Overview and Report Coverage An electric transfer chair is a specialized mobility device designed to assist individuals in moving safely and comfortably from one sitting surface to another, such as from a wheelchair to a bed or a car. These chairs are especially beneficial for individuals with limited mobility or physical disabilities. The Electric Transfer Chairs Market is expected to experience steady growth in the coming years, with a
Hospital Foam Mattresses Market Size 2024 to 2031.
Hospital Foam Mattresses Market Size 2024 to 2031.
Market Overview and Report Coverage A Hospital Foam Mattress is designed to provide patients with comfort and support during their stay in healthcare facilities. These mattresses are specifically crafted to prevent pressure ulcers, support proper body alignment, and aid in overall patient recovery. The Hospital Foam Mattresses Market is expected to see significant growth in the coming years, with a projected Compound Annual Growth Rate (CAGR) of 12.40% during
Orthopedic Surgery Bone Cements Market Size 2024 to 2031.
Orthopedic Surgery Bone Cements Market Size 2024 to 2031.
Market Overview and Report Coverage Orthopedic Surgery Bone Cements are biocompatible materials used in orthopedic surgeries to anchor prosthetic joints or fill bone defects. The Orthopedic Surgery Bone Cements Market is expected to grow at a CAGR of 10.50% during the forecasted period, driven by factors such as an increasing number of orthopedic surgeries due to the rising prevalence of bone-related disorders and an aging population. The current outlook of

All 5 Releases

More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug